Table 3.
Gene | Expression of Cell Line |
---|---|
KRAS | Occurred in almost all of the primary tumors of pancreatic cancer, but the BxPC-3 cell line is WT |
SMD4/DPC4 | Capan-2, MIA PaCa-2, PANC-1, SU.86.86 without SMD4 gene inactivation |
TP53 | Its mutation occurs in 50% of pancreatic malignant tumors and is associated with late tumor progression |
CDKN2A/P16 | Basically all pancreatic cancer cell lines have inactivation of the P16 gene |